What are analysts'target prices for Jasper Therapeutics'stock?
4 equities research analysts have issued 1-year target prices for Jasper Therapeutics' stock. Their forecasts range from $15.00 to $21.00. On average, they expect Jasper Therapeutics' stock price to reach $18.33 in the next twelve months. This suggests a possible upside of 109.0% from the stock's current price.
Who are the major shareholders of Jasper Therapeutics?
Top institutional shareholders include Abingworth LLP (15.41%), Citadel Advisors LLC (8.23%), Morgan Stanley (0.30%), Jane Street Group LLC (0.07%) and Tudor Investment Corp Et Al (0.05%). Which major investors are buying Jasper Therapeutics stock?
Where can I buy shares of JSPR?
Shares of JSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Jasper Therapeutics a good stock to buy?
Jasper Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
What is the stock symbol for Jasper technologies?
Stock Quote (U.S.: Nasdaq) | MarketWatch....$ 1.9200.CloseChgChg %$1.9200-0.1300-6.34%
Is Jasper going public?
Jasper is the 68th Bay Area company to go public this year, the most in more than two decades.
Is JSPR a good stock to buy?
Out of 5 analysts, 1 (20%) are recommending JSPR as a Strong Buy, 4 (80%) are recommending JSPR as a Buy, 0 (0%) are recommending JSPR as a Hold, 0 (0%) are recommending JSPR as a Sell, and 0 (0%) are recommending JSPR as a Strong Sell. What is JSPR's earnings growth forecast for 2022-2024?
Who bought Jasper?
CiscoCisco announced today it was buying Jasper Technologies, developers of an Internet of Things cloud platform for $1.4 billion.
What does Jasper Technologies do?
Cisco Jasper is a branch of the networking company that provides a cloud-based software platform for businesses looking to provide cloud services. Jasper allows Cisco customers to provide cloud services without investing large amounts of money to independently develop their own AI.
Should I buy or sell Jasper Therapeutics stock right now?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Jasper Therapeutics in the last twelve months. There are currently 5 buy r...
What is Jasper Therapeutics' stock price forecast for 2022?
5 analysts have issued twelve-month price objectives for Jasper Therapeutics' stock. Their forecasts range from $10.00 to $21.00. On average, they...
How has Jasper Therapeutics' stock price performed in 2022?
Jasper Therapeutics' stock was trading at $7.85 on January 1st, 2022. Since then, JSPR shares have decreased by 62.5% and is now trading at $2.94....
When is Jasper Therapeutics' next earnings date?
Jasper Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for...
How were Jasper Therapeutics' earnings last quarter?
Jasper Therapeutics, Inc. (NASDAQ:JSPR) announced its earnings results on Thursday, May, 12th. The company reported ($0.35) earnings per share for...
Who are Jasper Therapeutics' key executives?
Jasper Therapeutics' management team includes the following people: Dr. Judith Anne Shizuru M.D. , Ph.D., Co-Founder, Chair of Scientific Advisor...
Who are some of Jasper Therapeutics' key competitors?
Some companies that are related to Jasper Therapeutics include Aura Biosciences (AURA) , Caribou Biosciences (CRBU) , Humacyte (HUMA) , Kodiak...
What is Jasper Therapeutics' stock symbol?
Jasper Therapeutics trades on the NASDAQ under the ticker symbol "JSPR."
Who are Jasper Therapeutics' major shareholders?
Jasper Therapeutics' stock is owned by a number of institutional and retail investors. Top institutional investors include Sectoral Asset Managemen...
Headlines
Jasper Therapeutics (NASDAQ:JSPR) Frequently Asked Questions
Jasper Therapeutics Stock Is up 127% in Three Days. How Much Higher Can It Go?
